Compare, Analyse Torrent Pharma with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TORRENT PHARMA vs ACTAVIS (US) - Comparison Results

TORRENT PHARMA     Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 TORRENT PHARMA   ACTAVIS
EQUITY SHARE DATA
    TORRENT PHARMA
Mar-18
ACTAVIS
Dec-18
TORRENT PHARMA/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs1,55013,754-   
Low Rs1,1449,226-   
Sales per share (Unadj.) Rs354.73,373.8-  
Earnings per share (Unadj.) Rs40.1-1,086.7-  
Cash flow per share (Unadj.) Rs64.2355.5-  
Dividends per share (Unadj.) Rs14.000-  
Dividend yield (eoy) %1.00-  
Book value per share (Unadj.) Rs273.113,915.5-  
Shares outstanding (eoy) m169.22332.60-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.83.4 111.5%   
Avg P/E ratio x33.6-10.6 -317.8%  
P/CF ratio (eoy) x21.032.3 64.9%  
Price / Book Value ratio x4.90.8 597.1%  
Dividend payout %34.90-   
Avg Mkt Cap Rs m227,8973,821,601 6.0%   
No. of employees `00014.716.9 87.0%   
Total wages/salary Rs m11,3530-   
Avg. sales/employee Rs Th4,083.066,398.8 6.1%   
Avg. wages/employee Rs Th772.30-   
Avg. net profit/employee Rs Th461.3-21,387.1 -2.2%   
INCOME DATA
Net Sales Rs m60,0211,122,140 5.3%  
Other income Rs m2,98821,459 13.9%   
Total revenues Rs m63,0091,143,599 5.5%   
Gross profit Rs m13,49329,406 45.9%  
Depreciation Rs m4,086479,690 0.9%   
Interest Rs m3,08564,754 4.8%   
Profit before tax Rs m9,310-493,580 -1.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0125,883 0.0%   
Tax Rs m2,529-6,255 -40.4%   
Profit after tax Rs m6,781-361,442 -1.9%  
Gross profit margin %22.52.6 857.8%  
Effective tax rate %27.21.3 2,143.2%   
Net profit margin %11.3-32.2 -35.1%  
BALANCE SHEET DATA
Current assets Rs m52,623460,243 11.4%   
Current liabilities Rs m52,022407,146 12.8%   
Net working cap to sales %1.04.7 21.2%  
Current ratio x1.01.1 89.5%  
Inventory Days Days12020 610.6%  
Debtors Days Days7666 115.0%  
Net fixed assets Rs m85,016127,020 66.9%   
Share capital Rs m8460-   
"Free" reserves Rs m45,3760-   
Net worth Rs m46,2224,628,303 1.0%   
Long term debt Rs m41,1151,629,793 2.5%   
Total assets Rs m142,4327,235,091 2.0%  
Interest coverage x4.0-6.6 -60.7%   
Debt to equity ratio x0.90.4 252.6%  
Sales to assets ratio x0.40.2 271.7%   
Return on assets %6.9-4.1 -168.9%  
Return on equity %14.7-7.8 -187.9%  
Return on capital %14.2-4.8 -293.2%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m10,9800-   
CASH FLOW
From Operations Rs m8,942400,898 2.2%  
From Investments Rs m-47,070220,241 -21.4%  
From Financial Activity Rs m34,174-688,062 -5.0%  
Net Cashflow Rs m-3,655-66,588 5.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 71.08 Rs / USD

Compare TORRENT PHARMA With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare TORRENT PHARMA With: SUN PHARMA  ORCHID PHARMA LTD  IPCA LABS  PLETHICO PHARMA  WOCKHARDT  



Today's Market

Indian Stock Markets Remain in Green This Week: Is the Rebound Here?(Podcast)

After a long period of underperformance, stock markets traded in green territory throughout the week. So, is this is a trend reversal and is the bottom forming in the market?

Related Views On News

TORRENT PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 32.5% (Quarterly Result Update)

Jul 25, 2019 | Updated on Jul 25, 2019

For the quarter ended June 2019, TORRENT PHARMA has posted a net profit of Rs 2 bn (up 32.5% YoY). Sales on the other hand came in at Rs 20 bn (up 8.0% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

TORRENT PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 166.7% (Quarterly Result Update)

May 22, 2019 | Updated on May 22, 2019

For the quarter ended March 2019, TORRENT PHARMA has posted a net profit of Rs 2 bn (down 166.7% YoY). Sales on the other hand came in at Rs 19 bn (up 7.8% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

Two Stocks to Buy in the Great Indian Festival (Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound (The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TORRENT PHARMA SHARE PRICE


Oct 18, 2019 (Close)

TRACK TORRENT PHARMA

  • Track your investment in TORRENT PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TORRENT PHARMA

TORRENT PHARMA - SANOFI INDIA COMPARISON

COMPARE TORRENT PHARMA WITH

MARKET STATS